CIBC Private Wealth Group’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$284 Sell
7
-123
-95% -$5.35K ﹤0.01% 3150
2025
Q3
$6.11K Hold
130
﹤0.01% 2517
2025
Q2
$6.77K Hold
130
﹤0.01% 2381
2025
Q1
$6.74K Hold
130
﹤0.01% 2370
2024
Q4
$8.94K Hold
130
﹤0.01% 2301
2024
Q3
$9.35K Hold
130
﹤0.01% 2423
2024
Q2
$8.59K Hold
130
﹤0.01% 2337
2024
Q1
$10.3K Buy
+130
New +$11.6K ﹤0.01% 2260

Other funds holding CNMD

CIBC Private Wealth Group's CNMD Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its CONMED (CNMD) stake by 95% in Q4 2025, selling an estimated $5.35K and leaving 7 shares worth $284. The position accounts for ﹤0.01% of the portfolio, ranked #3150.

CIBC Private Wealth Group first reported a position in CNMD in Q1 2024 and has held it in 8 quarters since. The position peaked at $10.3K in Q1 2024. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2025.

  • CIBC Private Wealth Group held 7 shares of CONMED worth $284 as of Q4 2025.
  • CIBC Private Wealth Group sold 123 CONMED shares in Q4 2025, an estimated $5.35K.
  • CONMED made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3150 holding.
  • CIBC Private Wealth Group first reported a position in CONMED in Q1 2024 and has held it in 8 quarters since.
  • CIBC Private Wealth Group's CONMED position peaked at $10.3K in Q1 2024.
  • 265 funds tracked by Wall St. Rank held CONMED as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.